- 172 -

- 173 -

- 174 -

1000 900 900 800 700 600 500 400 300 298 331 356 390 427 498 559 602 650 200 100 0 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010-175 -

. - 176 -

No. 제품명성분명회사명 2006 년 2007 년성장율제품년수 1 Lipitor atorvastatin Pfizer+Astellas+Almirall 13,801 13,660-1.0 11.3 2 Plavix clopidogrel BMS+Sanofi-Aventis 6,057 8,079 33.4 10.3 3 Seretide/Advair fluticasone propionate & salmeterol xinofoate GSK+Almirall+Others 6,277 7,198 14.7 9.7 4 Epogen/Procrit/Eprex epoetin alfa J&J+Amgen+Kirin 6,037 5,729-5.1 19.4 5 Enbrel etanercept Amgen+Takeda+Wyeth 4,476 5,440 21.5 9.6 6 Nexium esomeprazole magnesium AstraZeneca 5,182 5,216 0.7 7.8 7 Diovan valsartan Novartis+Ipsen+UCB 4,334 5,151 18.9 11.7 8 Zyprexa olanzapine Eli Lilly 4,364 4,761 9.1 11.7 9 Rituxan/MabThera rituximab Roche+Genentech 3,782 4,509 19.2 10.5 10 Singulair montelukast Merck+Kyorin 3,707 4,434 19.6 10.3 11 Remicade infliximab J&J+Schering+Mitsubishi 3,770 4,433 17.6 9.8 12 Seroquel quetiapine AstraZeneca+Astellas 3,560 4,196 17.9 10.7 13 Herceptin trastuzumab Roche+Genentech 3,134 4,046 29.1 9.7 14 Effexor venlafaxine Wyeth+Almirall 3,789 3,864 2.0 14.2 15 Protonix pantoprazole Wyeth+Nycomed+Others 3,539 3,828 8.2 13.8 16 Aranesp dabepoetin alfa Amgen+Kirin 4,121 3,657-11.3 6.9 17 Levenox/Clexane enoxaparin Sanofi-Aventis 3,059 3,582 17.1 20.4 18 Norvasc/Amlodin amlodipine besylate Pfizer+Sumitomo+Almirall 5,397 3,581-33.6 17.4 19 Actos pioglitazone Takeda+Abbott 2,934 3,535 20.5 8.8 20 Risperdal risperidone Johnson & Johnson 3,338 3,440 3.1 14.4 21 Avastin bevacizumab Roche+Genentech 2,364 3,422 44.8 4.3 22 Cozaar losartan Merck 3,163 3,350 5.9 13.3 23 Fosamax alendronate Merck+Teijin 3,262 3,187-2.3 14.4 24 Prevacid/Takepron/Zoton lansoprazole TAP+Takeda 3,450 3,185-7.7 16.4 25 Lexapro escitalopram oxalate Forest Labs+Lundbeck 2,778 3,152 13.5 6.2 26 Humira adalimumab Abbott 2,044 3,064 49.9 5.4 27 Gleevec/Glivec imatinib besylate Novartis 2,554 3,050 19.4 7.1 28 Neulasta pegfilgrastim Amgen 2,710 3,000 10.7 6.1 29 Aricept donepezil Pfizer+Eisai 2,521 2,957 17.3 11.3 30 Crestor rosuvastatin AstraZeneca+Shionogi 2,087 2,930 40.4 5.3 31 Lantus insulin glargine Sanofi-Aventis 2,093 2,785 33.1 7.9 32 Vytorin simvastatin+ezetimibe Merck/Schering 1,933 2,761 42.8 4.1 33 Avapro irbesartan Sanofi-Aventis+BMS 2,372 2,685 13.2 10.7 34 Abilify aripiprazole Otsuka Pharmaceutical 1,957 2,638 34.8 5.5 35 Human insulin & devices insulin Novo Nordisk 2,536 2,636 3.9-36 Taxotere docetaxel Sanofi-Aventis 2,201 2,570 16.8 12.4 37 Atacand/Blopress candesartan cilexetil AstraZeneca+Takeda+Almirall 2,255 2,540 12.6 10.4 38 Zetia ezetimibe Merck/Schering 1,954 2,514 28.7 5.5 39 Spiriva tiotropium Boehringer Ingelheim+Pfizer 1,735 2,457 41.6 6.0 40 Topamax topiramate J&J 2,027 2,453 21.0 11.4 41 Prevnar pneumococcal vaccine Wyeth 1,961 2,439 24.4 8.2 42 Cravit/Levaquin levofloxacin J&J+Daiichi Sankyo 2,243 2,391 6.6 14.5 43 Actonel risedronate P&G+Sanofi-Aventis 2,151 2,381 10.7 9.6 44 Aciphex/Pariet rabeprazole J&J+Eisai 2,187 2,354 7.6 10.5 45 Celebrex celecoxib Pfizer+Astellas 2,039 2,322 13.9 9.3 46 Micardis telmisartan Boehringer+Astellas+Bayer 1,749 2,206 26.1 9.5 47 Lamictal lamotrigine GSK 1,836 2,196 19.6 13.4 48 Flomax/Alna/Harnal tamsulosin Boehringer+Astellas 1,855 2,171 17.0 14.8 49 Cymbalta/Xeristar duloxetine Eli Lilly 1,316 2,103 59.8 3.8 50 Insulin Analogues insulin Novo Nordisk 1,588 2,096 32.0 8.7 Total 161,579 182,334 12.8 10.3-177 -

- 178 -

- 179 -

- 180 -

- 181 -

- 182 -

- 183 -

- 184 -

- 185 -

기타유럽, 30.30% 프랑스, 19.90% 영국, 14% 이탈리아, 16% 독일, 19.90% - 186 -

- 187 -

- 188 -

- 189 -

- 190 -

- 191 -

- 192 -

- 193 -

- 194 -

- 195 -

- 196 -

- 197 -

- 198 -

- 199 -